Concord Drugs Limited Share Price
Concord Drugs Limited Share Price Today
As of 5 Jul 2026, Concord Drugs Limited share price is ₹77.45. The stock opened at ₹76.63, compared to its previous close of ₹76.08. During today's trading session, Concord Drugs Limited share price moved in the range of ₹76.63 to ₹77.50, with an average price of ₹77.06 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.00 and a high of ₹92.52.
Concord Drugs Limited Returns Calculator
Concord Drugs Limited Shareholder Returns
Concord Drugs Limited Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Concord Drugs Limited Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹45.24 | ₹44.92 | ₹52.08 | ₹58.96 |
| Other Income | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.10 |
| Total Revenue | ₹45.26 | ₹44.93 | ₹52.09 | ₹59.06 |
| Total Expenses | ₹44.57 | ₹44.30 | ₹50.84 | ₹56.81 |
| Profit Before Tax | ₹0.69 | ₹0.63 | ₹1.25 | ₹2.25 |
| Tax | ₹0.36 | ₹0.16 | ₹0.26 | ₹0.65 |
| Profit After Tax | ₹0.34 | ₹0.47 | ₹0.99 | ₹1.59 |
| EPS - Basic | ₹0.34 | ₹0.47 | ₹1.06 | ₹1.82 |
| EPS - Diluted | ₹0.34 | ₹0.47 | ₹1.06 | ₹1.82 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹0.69 | ₹0.63 | ₹1.25 | ₹2.25 |
| Income before WC changes | ₹4.13 | ₹4.04 | ₹4.51 | ₹5.41 |
| Change in Assets | -₹5.50 | -₹1.10 | ₹6.21 | -₹5.86 |
| Change in Liabilities | ₹5.29 | -₹1.93 | -₹8.67 | ₹1.89 |
| Change in WC | -₹0.21 | -₹3.03 | -₹2.46 | -₹3.97 |
| Cash flow from Operations | ₹3.72 | ₹0.79 | ₹1.66 | ₹0.77 |
| Cash flow from Investing | -₹2.32 | -₹1.01 | -₹2.27 | -₹2.44 |
| Cash flow from Financing | -₹1.43 | ₹0.28 | ₹0.62 | ₹1.68 |
| Total Cash Flow | -₹0.02 | ₹0.07 | ₹0.02 | ₹0.01 |
| Cash (Start of the year) | ₹0.15 | ₹0.08 | ₹0.06 | ₹0.04 |
| Cash (End of the year) | ₹0.12 | ₹0.15 | ₹0.08 | ₹0.04 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹24.38 | ₹21.29 | ₹14.77 | ₹14.55 |
| Current Assets | ₹40.76 | ₹37.52 | ₹43.46 | ₹41.89 |
| Total Assets | ₹65.14 | ₹58.81 | ₹58.23 | ₹56.45 |
| Current Liabilities | ₹26.18 | ₹21.00 | ₹21.61 | ₹23.65 |
| Net Current Asset | ₹14.58 | ₹16.51 | ₹21.84 | ₹18.24 |
| Non-Current Liabilities | ₹4.85 | ₹3.98 | ₹4.91 | ₹4.44 |
| Equity Capital | ₹34.11 | ₹33.82 | ₹31.70 | ₹28.36 |
| Total Equity & Liabilities | ₹65.14 | ₹58.81 | ₹58.23 | ₹56.45 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹36.93 | ₹43.26 | ₹51.31 | ₹58.96 |
| Other Income | ₹0.01 | ₹0.01 | ₹0.01 | ₹0.10 |
| Total Revenue | ₹36.95 | ₹43.27 | ₹51.32 | ₹59.06 |
| Total Expenses | ₹36.31 | ₹42.71 | ₹50.20 | ₹56.81 |
| Profit Before Tax | ₹0.64 | ₹0.56 | ₹1.13 | ₹2.25 |
| Tax | ₹0.35 | ₹0.14 | ₹0.23 | ₹0.65 |
| Profit After Tax | ₹0.30 | ₹0.42 | ₹0.89 | ₹1.59 |
| EPS - Basic | ₹0.30 | ₹0.42 | ₹0.96 | ₹1.82 |
| EPS - Diluted | ₹0.30 | ₹0.42 | ₹0.96 | ₹1.82 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹0.64 | ₹0.56 | ₹1.13 | ₹2.25 |
| Income before WC changes | ₹3.76 | ₹3.68 | ₹4.28 | ₹5.41 |
| Change in Assets | -₹1.39 | ₹0.08 | ₹0.51 | -₹5.86 |
| Change in Liabilities | ₹0.98 | -₹1.59 | -₹2.20 | ₹1.89 |
| Change in WC | -₹0.41 | -₹1.51 | -₹1.68 | -₹3.97 |
| Cash flow from Operations | ₹3.16 | ₹1.96 | ₹2.24 | ₹0.77 |
| Cash flow from Investing | -₹2.32 | -₹1.21 | -₹2.27 | -₹2.44 |
| Cash flow from Financing | -₹0.87 | -₹0.69 | ₹0.05 | ₹1.68 |
| Total Cash Flow | -₹0.02 | ₹0.06 | ₹0.03 | ₹0.01 |
| Cash (Start of the year) | ₹0.14 | ₹0.08 | ₹0.04 | ₹0.04 |
| Cash (End of the year) | ₹0.12 | ₹0.14 | ₹0.08 | ₹0.04 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹25.16 | ₹22.01 | ₹15.23 | ₹14.55 |
| Current Assets | ₹33.42 | ₹34.28 | ₹41.40 | ₹41.89 |
| Total Assets | ₹58.58 | ₹56.30 | ₹56.63 | ₹56.45 |
| Current Liabilities | ₹19.62 | ₹19.11 | ₹20.90 | ₹23.65 |
| Net Current Asset | ₹13.80 | ₹15.18 | ₹20.50 | ₹18.24 |
| Non-Current Liabilities | ₹4.84 | ₹3.37 | ₹4.03 | ₹4.44 |
| Equity Capital | ₹34.11 | ₹33.82 | ₹31.70 | ₹28.36 |
| Total Equity & Liabilities | ₹58.58 | ₹56.30 | ₹56.63 | ₹56.45 |
About Concord Drugs Limited
Concord Drugs Limited is an India-based pharmaceutical company. The Company's principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. It operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The Company's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). It also offers hand sanitizers under the brand name, PROTON SAFE. It manufactures hand sanitizers on third party basis also. The Company's oral liquid dosage forms include solutions, syrups, and suspensions.
Concord Drugs Limited Financial Highlights
- Revenue: Concord Drugs Limited reported revenue of ₹78.77 crore in FY26 vs ₹45.26 crore in FY25. It showed an increase of 74.04% on a yearly basis.
- Operating Profit: Concord Drugs Limited reported an operating profit of ₹1.47 crore in FY26 vs ₹0.69 crore in FY25. It showed an increase of 113.04% on a year-on-year basis.
- Net Profit: Concord Drugs Limited reported a net profit of ₹1.06 crore in FY26 vs ₹0.34 crore in FY25. It showed an increase of 211.76% on a yearly basis.
Concord Drugs Limited Quarterly Result Highlights
- Concord Drugs Limited reported revenue of ₹37.90 crore in Mar 2026, compared with ₹16.99 crore in Dec 2025, representing an increase of 123.07% on a quarter-on-quarter (QoQ) basis.
- Concord Drugs Limited reported an operating profit of ₹0.75 crore in Mar 2026, compared with ₹0.30 crore in Dec 2025, representing an increase of 150.00% on a quarter-on-quarter (QoQ) basis.
- Concord Drugs Limited reported a profit of ₹0.53 crore in Mar 2026, compared with ₹0.22 crore in Dec 2025, reflecting an increase of 140.91% on a QoQ basis.
- The earnings per share (EPS) of Concord Drugs Limited stood at ₹0.34 during Mar 2026.
Similar Stocks
FAQs on Concord Drugs Limited Share Price
What is Concord Drugs Limited share price today?
Concord Drugs Limited share price is ₹77.45 as on 03 Jul, 2026, 15:25 IST.
How has the Concord Drugs Limited share price performed in the past?
In the last 1 year, Concord Drugs Limited delivered a return of 45.34%. The Concord Drugs Limited share price hit a high of ₹92.52 and low of ₹49.00.
How much is the Mutual Fund shareholding in Concord Drugs Limited shares?
The Mutual Fund Shareholding in Concord Drugs Limited was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Concord Drugs Limited shares ?
The 52-week high and low of Concord Drugs Limited share is ₹92.52 and ₹49.00 as of 03 Jul, 2026.
What is the market cap of Concord Drugs Limited?
The market capitalisation of Concord Drugs Limited is ₹100.24 Crores as on 03 Jul, 2026.
What are the stock symbols of Concord Drugs Limited?
The stock symbol of Concord Drugs Limited is 538965 on the BSE, and the ISIN is INE858L01010.
What was yesterday's closing price for Concord Drugs Limited shares ?
Concord Drugs Limited shares closed yesterday at ₹76.08 on BSE
How to buy Concord Drugs Limited shares?
To buy Concord Drugs Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Concord Drugs Limited shares on Holidays?
No, shares of Concord Drugs Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Concord Drugs Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Concord Drugs Limited?
The PE and PB ratio of Concord Drugs Limited is 95.1 and 2.07 respectively, as on 03 Jul, 2026, 15:25 IST.